Major Allergan Investor Joins Chorus Against Salix Deal by DAVID GELLES

By DAVID GELLES

In a letter to Allergan’s board, Jackson Square Partners, which represents more than $1 billion in Allergan shares, questioned the company’s strategy to fend off a hostile takeover.

Published: September 27, 2014 at 4:00AM

from NYT Business Day http://ift.tt/1sDpILS

via IFTTT

from WordPress http://ift.tt/1nlJx8k